France says pharma giant Sanofi could make rivals' Covid vaccines

Friday, 15 January 2021, 13:31:40
…
— RTL Today

Sanofi to acquire Babraham Research Campus-based Kymab in deal worth up to $1.45bn

Friday, 15 January 2021, 12:03:00
The deal is expected to be completed in the first half of 2021.
— Cambridge Independent

Before Summer 36 Percent of Bulgarians Will Be Vaccinated

Friday, 15 January 2021, 10:22:41
Nearly 36% of the population of Bulgaria may be vaccinated in the first six months of this year, BGNES learnt from the press office of the Ministry of Health. “By the end of the first half of 2021, given 5 types of vaccines we will be able to vaccinate 2.3 million people or about 36% of the population of the country, not including children up to the age of 16,” the health ministry said in response to questions of BGNES. The Ministry of Health has undertaken a policy of diversification of the vaccine portfolio – that is, to participate in the contracts for all vaccines for which the EC has concluded contracts. The aim is to ensure the rapid implementation of all stages of the vaccination plan. Bulgaria has requested vaccines from five manufacturers, i.e. sufficient quantities of vaccines for 6 million people will be provided, assuming that all vaccines are two-dose and that children up to 16 years old are not inoculated at this stage,” the health ministry said. The health officials also clarified that “for the other two vaccines manufacturers – namely Sanofi and Novavax, with which the EC is expected to conclude a contract – quantities are also foreseen and are estimated as sufficient for 3 million people.
— Novinite